Serina Therapeutics Inc (SER) News

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a...

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug...

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024Lead...

Drilling Report

RNS Number:3996U Sefton Resources Inc 20 January 2004 Sefton Resources, Inc. ("Sefton" or "The Company") Second successful gas test...

Issue of Equity

RNS Number:3034U Sefton Resources Inc 16 January 2004 Sefton Resources, Inc. ("the Company") Placing of 100,000,000 New Common Shares at...

3rd Quarter Results

RNS Number:8732T Sefton Resources Inc 06 January 2004 SEFTON RESOURCES INC. ("Sefton" or "The Company") Results for the nine...

Issue of Equity

RNS Number:0542S Sefton Resources Inc 13 November 2003 Sefton Resources, Inc. ("the Company") Placing of 55,000,000 New Common Shares at...

Issue of Equity

RNS Number:6718R Sefton Resources Inc 04 November 2003 Sefton Resources, Inc. ("the Company") Placing of 32,000,000 New Common Shares at...

Issue of Equity

RNS Number:4039R Sefton Resources Inc 28 October 2003 Sefton Resources, Inc. ("the Company") Placing of 32,000,000 New Common Shares at...